phthalocyanine has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, JQ; Hu, QY; Huang, JD; Ke, MR; Li, D; Li, X; Wang, XZ; Zheng, BY | 1 |
Hu, JQ; Huang, JD; Huang, ZL; Ke, MR; Lan, WL; Li, X; Lv, LL; Zheng, BD; Zheng, BY | 1 |
2 other study(ies) available for phthalocyanine and Experimental Hepatoma
Article | Year |
---|---|
A non-aggregated silicon(IV) phthalocyanine-lactose conjugate for photodynamic therapy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Coordination Complexes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Indoles; Isoindoles; Lactose; Liver Neoplasms, Experimental; Mice; Molecular Structure; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Silicon; Structure-Activity Relationship | 2020 |
A pH-sensitive nanoagent self-assembled from a highly negatively-charged phthalocyanine with excellent biosafety for photothermal therapy.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Indoles; Isoindoles; Liver Neoplasms, Experimental; Mice; Molecular Structure; Nanoparticles; Photothermal Therapy; Zinc | 2021 |